2011 annual financial data

Sarepta Therapeutics 2011 Net margin

Sarepta Therapeutics 2011 net margin with verified reported values.

Direct answer

Net margin was -4.93%.

Operating income was -35,927,000 USD and net income was -2,318,000 USD.
Operating cash flow was -23,679,000 USD.

Get free Sarepta Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
46,990,000 USD
Operating income
-35,927,000 USD
Net income
-2,318,000 USD
Operating cash flow
-23,679,000 USD